IMVのRPE
IMVのRPEは何ですか。
IMV, Inc.のRPEは237.11$です。
RPEの定義は何ですか。
従業員1人当たりの収益（RPE）は、収益を組織の従業員の数で割ったものです。
TSXのセクタHealth CareにおけるRPEの企業と比べるIMV
IMVは何をしますか。
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
IMVと類似のrpe
- Premier African MineralsのRPEは181.82$です。
- GlycoMimetics IncのRPEは185.19$です。
- Parabolic DrugsのRPEは197.82₨です。
- VirnetX CorpのRPEは200.00$です。
- HighwayのRPEは201.15$です。
- First CapitalのRPEは205.52$です。
- IMVのRPEは237.11$です。
- Virnetx CorpのRPEは300.00$です。
- Sihayo GoldのRPEは339.97AUD$です。
- BELLUS HealthのRPEは375.00$です。
- BELLUS HealthのRPEは400.00$です。
- Aqua Metals IncのRPEは403.23$です。
- Oragenics IncのRPEは414.78$です。